Aromatase Inhibitor [EPC]: Side Effects & Safety Data for 3 Drugs
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Aromatase Inhibitor [EPC] includes 3 drugs with a combined 52,966 adverse event reports in the FDA FAERS database. Compare their safety profiles, side effects, and outcomes below.
3
Drugs in Class
52,966
Combined Reports
All Aromatase Inhibitor [EPC] Drugs Ranked by Reports
| Drug | Brand Name | Reports | Deaths | Hosp. | Death Rate |
|---|---|---|---|---|---|
| LETROZOLE | Letrozole | 31,154 | 3,024 | 8,637 | 9.7% |
| ANASTROZOLE | Anastrozole | 11,394 | 927 | 2,427 | 8.1% |
| EXEMESTANE | Exemestane | 10,418 | 1,256 | 2,327 | 12.1% |
Common Side Effects in Aromatase Inhibitor [EPC] Drugs
| Side Effect | Reports | Deaths |
|---|---|---|
| Fatigue | 5,905 | 940 |
| Malignant neoplasm progression | 5,476 | 732 |
| Nausea | 4,856 | 901 |
| Arthralgia | 4,670 | 687 |
| Neutropenia | 4,468 | 204 |
| Diarrhoea | 4,074 | 887 |
| Dyspnoea | 2,972 | 1,017 |
| Metastases to bone | 2,931 | 193 |
| Asthenia | 2,835 | 813 |
| Vomiting | 2,682 | 828 |